Skip to main content
TipRanks
Go Ultimate75% OFF

Addex Therapeutics (ADXN) Income Statement

2 Followers

Addex Therapeutics Income Statement

Last quarter (Q2 2026), Addex Therapeutics's total revenue was CHF9.95K, a decrease of 66.53% from the same quarter last year. In Q2, Addex Therapeutics's net income was CHF-1.75M. See Addex Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementMar 26Mar 25Mar 24Dec 22Dec 21
CHF 173.00KCHF 410.04KCHF 1.61MCHF 1.42MCHF 2.92M
CHF 164.39KCHF -444.26KCHF -5.32MCHF -13.20MCHF -9.67M
CHF 2.99MCHF 2.31MCHF 2.67MCHF 3.76MCHF 5.84M
Depreciation and AmortizationCHF 8.47KCHF 260.12KCHF 305.95KCHF 323.14KCHF 347.61K
CHF -2.81MCHF -4.65MCHF -10.26MCHF -20.43MCHF -14.94M
CHF -2.81MCHF -2.76MCHF -2.24MCHF -20.52MCHF -15.51M
CHF -4.03MCHF -2.15MCHF -257.19KCHF -284.01KCHF 154.00K
CHF -6.84MCHF -4.91MCHF -2.50MCHF -20.80MCHF -15.35M
CHF -6.73MCHF 7.06MCHF -10.56MCHF -20.80MCHF -15.41M
Per Share Metrics
Basic EPSCHF -0.06CHF 0.07CHF -0.14CHF -0.46CHF -0.45
Diluted EPSCHF -0.06CHF 0.07CHF -0.14CHF -0.46CHF -0.45
Weighted Average Shares Outstanding112.15M98.11M74.31M45.18M34.12M
Weighted Average Shares Outstanding (Diluted)112.15M98.34M74.31M45.18M34.12M

Currency in CHF

Addex Therapeutics Earnings and Revenue History

-24M-12M012M-5000 %-2500 %0 %2500 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin